Cargando…
Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this disease remains a major cause of mortality and morbidity. Recent progress over the last two decades in the field of molecular genetics, especially with new tools such as genome-wide association studies, has h...
Autores principales: | Vrablik, Michal, Dlouha, Dana, Todorovova, Veronika, Stefler, Denes, Hubacek, Jaroslav A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074003/ https://www.ncbi.nlm.nih.gov/pubmed/33920733 http://dx.doi.org/10.3390/ijms22084182 |
Ejemplares similares
-
SLCO1B1 Polymorphism is not associated with Risk of Statin-Induced Myalgia/Myopathy in a Czech Population
por: Hubáček, Jaroslav A., et al.
Publicado: (2015) -
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetics and Biochemical Parameters
por: Todorovova, Veronika, et al.
Publicado: (2022) -
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics
por: Altschmiedova, Tereza, et al.
Publicado: (2022) -
Posttransplant Complications and Genetic Loci Involved in Telomere Maintenance in Heart Transplant Patients
por: Dlouha, Dana, et al.
Publicado: (2022) -
Genetics of Familial Hypercholesterolemia: New Insights
por: Vrablik, Michal, et al.
Publicado: (2020)